COMPASS PATHW SP.ADR (5Y6) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.715x

Based on the latest financial reports, COMPASS PATHW SP.ADR (5Y6) has a cash flow conversion efficiency ratio of 0.715x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-37.79 Million ≈ $-44.18 Million USD) by net assets (€-52.85 Million ≈ $-61.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

COMPASS PATHW SP.ADR - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how COMPASS PATHW SP.ADR's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read COMPASS PATHW SP.ADR total liabilities for a breakdown of total debt and financial obligations.

COMPASS PATHW SP.ADR Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of COMPASS PATHW SP.ADR ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Momentum Group AB (publ)
ST:MMGR-B
0.046x
Gansu Golden Glass Technologies Co Ltd
SHE:300093
0.043x
Korea Investment Holdings Co Ltd
KO:071055
-0.587x
Shanghai Golden Bridge
SHG:603918
0.043x
SZZT Electronics Co Ltd
SHE:002197
0.019x
Tongyang Inc
KO:001525
-0.001x
Biotest Aktiengesellschaft
XETRA:BIO3
-0.114x
ECOVE Environment Corp
TWO:6803
-0.287x

Annual Cash Flow Conversion Efficiency for COMPASS PATHW SP.ADR (2021–2025)

The table below shows the annual cash flow conversion efficiency of COMPASS PATHW SP.ADR from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see 5Y6 company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €-52.85 Million
≈ $-61.78 Million
€-157.24 Million
≈ $-183.83 Million
2.975x +486.18%
2024-12-31 €154.69 Million
≈ $180.85 Million
€-119.19 Million
≈ $-139.34 Million
-0.770x -78.61%
2023-12-31 €225.74 Million
≈ $263.92 Million
€-97.38 Million
≈ $-113.84 Million
-0.431x +25.85%
2022-12-31 €181.28 Million
≈ $211.94 Million
€-105.45 Million
≈ $-123.28 Million
-0.582x -144.21%
2021-12-31 €284.41 Million
≈ $332.51 Million
€-67.75 Million
≈ $-79.20 Million
-0.238x --

About COMPASS PATHW SP.ADR

F:5Y6 Germany Medical Care Facilities
Market Cap
$841.91 Million
€720.13 Million EUR
Market Cap Rank
#11268 Global
#1267 in Germany
Share Price
€7.50
Change (1 day)
-3.23%
52-Week Range
€2.12 - €8.15
All Time High
€48.20
About

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as … Read more